SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
June 01, 2024 10:00 ET
|
Corbus Pharmaceuticals Holdings, Inc.
An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacySYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in mUC and 43% ORR and...
Lynch Carpenter Investigates Claims in Sav-RX Data Breach
May 31, 2024 17:21 ET
|
Lynch Carpenter
PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Sav-Rx recently announced that it suffered from a cybersecurity attack in October of 2023, which impacted the personal information of approximately 2.8...
Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034: Rising Opportunities for IBD Drugs in Asian Markets
May 31, 2024 06:32 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Inflammatory...
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
May 30, 2024 17:55 ET
|
Myriad Genetics, Inc.
Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved...
Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
May 30, 2024 08:00 ET
|
Corbus Pharmaceuticals Holdings, Inc.
NORWOOD, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of...
Psoriasis Drugs Market (2023-2034) to Grow by $28.85 Billion - Global and Regional Growth Opportunities for Hospital, Retail, and Online Pharmacies with Profiles of the Top 10+ Market Players
May 30, 2024 06:13 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Psoriasis Drugs Market" report has been added to ResearchAndMarkets.com's offering.The global psoriasis drugs market accounted for USD 12.41...
Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
May 29, 2024 13:46 ET
|
Lynch Carpenter
PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Cencora, Inc. recently announced that it suffered from a cybersecurity attack that occurred in February of 2024, which impacted the personal information...
Allergic Rhinitis Drugs Market Report 2024-2034: Launch of Effective and Novel Drug Delivery Systems Spurs Adoption, Growing Awareness About Treatment Options
May 29, 2024 04:16 ET
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Allergic Rhinitis Drugs Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.Allergic Rhinitis Drugs Market will surpass...
Benzoic Acid Market Is Expected To Reach A Revenue Of USD 1,853.5 Mn By 2033, At 5.3% CAGR: Dimension Market Research
May 27, 2024 10:48 ET
|
Dimension Market Research
New York, May 27, 2024 (GLOBE NEWSWIRE) -- Market Overview Global Benzoic Acid Market size is expected to reach USD 1,164.6 million by 2024 and is further anticipated to reach USD 1,853.5...
Global Pharmaceutical Industry Outlook 2024: Key Growth Opportunities in Scaling Precision Oncology in Asia-Pacific Through Public-private Partnership Models
May 27, 2024 04:33 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Industry Outlook, 2024" report has been added to ResearchAndMarkets.com's offering.The leading trends shaping the global...